Danaher Corporation (NYSE:DHR – Get Free Report)’s stock price passed below its 50 day moving average during trading on Friday. The stock has a 50 day moving average of $224.82 and traded as low as $219.92. Danaher shares last traded at $220.4190, with a volume of 3,990,094 shares changing hands.
Analyst Upgrades and Downgrades
A number of equities research analysts have recently weighed in on DHR shares. Wall Street Zen upgraded Danaher from a “hold” rating to a “buy” rating in a research report on Monday, October 26th. DZ Bank lowered Danaher from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, October 27th. Robert W. Baird upped their price objective on shares of Danaher from $246.00 to $254.00 and gave the stock an “outperform” rating in a report on Thursday, October 22nd. Royal Bank Of Canada boosted their price target on shares of Danaher from $215.00 to $250.00 and gave the company an “outperform” rating in a research report on Monday, October 5th. Finally, UBS Group reissued a “buy” rating and issued a $260.00 price target on shares of Danaher in a research note on Thursday, October 22nd. Eighteen equities research analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $242.91.
Get Our Latest Research Report on DHR
Danaher Stock Performance
The company has a quick ratio of 1.29, a current ratio of 1.63 and a debt-to-equity ratio of 0.45. The stock has a market capitalization of $155.07 billion, a P/E ratio of 36.08, a P/E/G ratio of 2.77 and a beta of 0.76. The business has a fifty day moving average price of $224.82 and a 200-day moving average price of $201.66.
Danaher (NYSE:DHR – Get Free Report) last posted its earnings results on Wednesday, October 21st. The conglomerate reported $2.11 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.92 by $0.19. The business had revenue of $6.55 billion for the quarter, compared to analysts’ expectations of $6.56 billion. Danaher had a net margin of 16.91% and a return on equity of 11.17%. The business’s revenue for the quarter was up 8.3% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.89 EPS. On average, sell-side analysts expect that Danaher Corporation will post 8.59 EPS for the current year.
Danaher Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Friday, October 30th. Investors of record on Wednesday, September 30th were given a dividend of $0.40 per share. The ex-dividend date was Wednesday, September 30th. This represents a $1.60 dividend on an annualized basis and a yield of 0.7%. Danaher’s dividend payout ratio is 26.19%.
Insider Activity at Danaher
In other news, CAO Christopher Bouda sold 7,598 shares of the stock in a transaction on Wednesday, October 28th. The stock was sold at an average price of $234.56, for a total transaction of $1,782,186.88. Following the transaction, the chief accounting officer directly owned 9,107 shares of the company’s stock, valued at $2,136,137.92. This represents a 45.48% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, EVP Gregory M. Milosevich sold 2,100 shares of the firm’s stock in a transaction on Monday, November 9th. The stock was sold at an average price of $230.62, for a total value of $484,302.00. Following the completion of the transaction, the executive vice president owned 22,367 shares in the company, valued at approximately $5,158,277.54. This trade represents a 8.58% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own 10.80% of the company’s stock.
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently bought and sold shares of DHR. Stonebrook Private Inc. purchased a new position in shares of Danaher in the third quarter worth approximately $250,000. PCM Encore LLC raised its position in Danaher by 6.5% in the third quarter. PCM Encore LLC now owns 1,334 shares of the conglomerate’s stock worth $296,000 after acquiring an additional 81 shares during the period. Defiance ETFs LLC boosted its stake in shares of Danaher by 14.4% during the 3rd quarter. Defiance ETFs LLC now owns 2,940 shares of the conglomerate’s stock worth $651,000 after acquiring an additional 371 shares during the last quarter. Tradewinds LLC. purchased a new position in shares of Danaher during the 3rd quarter worth $258,000. Finally, Advisors Asset Management Inc. bought a new stake in shares of Danaher during the 3rd quarter valued at $2,476,000. 79.05% of the stock is owned by hedge funds and other institutional investors.
About Danaher
Danaher is a global science and technology company that develops and supplies products and services for biotechnology, life sciences, and diagnostics markets. Its offerings include instruments, reagents, consumables, software, and services used in research, drug development and manufacturing, and clinical testing. The company’s businesses include well-known brands such as Cytiva and Pall in bioprocessing and filtration, Beckman Coulter in laboratory and clinical diagnostics, Cepheid in molecular diagnostics, and Leica Microsystems in microscopy.
Further Reading
- Five stocks we like better than Danaher
- Growing Pains Versus Growth: Is BJ’s Wholesale Club a Buying Opportunity?
- Keysight Technologies: The Tollbooth on the Technology Superhighway
- Zscaler Got a Boost From Palo Alto, But Now It Has to Deliver.
- Bargain Hunting: Why Off-Price Retail Is Winning
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
